Pfizer Inc (NYSE:PFE) shares, rose in value on Wednesday, June 18, with the stock price down by -0.50% to the previous day’s close as strong demand from buyers drove the stock to $23.88. Actively observing the price movement in the last trading, the stock closed
The trading price of Pfizer Inc (NYSE:PFE) closed lower on Friday, June 13, and closing at $24.54, -1.21% lower than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $24.46 and $24.95. The company’s P/E ratio
Pfizer Inc (NYSE:PFE) price on Wednesday, June 11, rose 0.74% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $24.48. A look at the stock’s price movement, the close in the last trading session was $24.30. The PE
Pfizer Inc (NYSE:PFE) price closed higher on Friday, June 06, and jumping 0.99% above its previous close. A look at the daily price movement shows that the last close reads $23.12. The company’s P/E ratio in the trailing 12-month period read 16.92. Taking into account
Pfizer Inc (NYSE:PFE) shares, rose in value, with the stock price up by 1.16% to the previous day’s close as strong demand from buyers drove the stock to $23.45. Actively observing the price movement in the last trading, the stock closed the session at $23.18.
The trading price of Pfizer Inc (NYSE:PFE) closed higher on Friday, May 23, and closing at $23.55, 0.96% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $23.365 and $23.58. The company’s P/E ratio
Pfizer Inc (NYSE:PFE) concluded the trading at $22.60 on current market day with a rise of 2.63% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $22.02 and 5Y monthly beta was
Pfizer Inc (NYSE:PFE) traded at $22.89 at last check on current trade day and made an upward move of 2.72% on its previous day’s price. Pfizer Inc has a market cap of $130.11 billion and is expected to release its quarterly earnings report in June.
Today we peer into the world of biotech stocks! This is a space that is often overlooked by investors for being too high-risk, but experts realize that this industry is much more than getting a good candidate through clinical trials. In recent years, biotechnology has
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.